ALMRY Financials: Almirall SA AI Analysis

Home

Stock

ALMRY

Financials

ALMRY Financial

Almirall SA

0%

$0

At close: Mar 27, 16:00:00 GMT-4

$14.28

0%

$0

Pre-market: Mar 30, 09:34:13 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$14.28

Open

$15.8

Day's Range

$14.28 - $15.8

52 week range

$11.5 - $15.8

Volume

100

Avg.Volume

Dividend yield

EPS (TTM)

0.25

Market Cap

$3.0B

What is Almirall SA?

Almirall SA is a global biopharmaceutical company, which is focused on skin health. The company is headquartered in Barcelona, Barcelona and currently employs 2,026 full-time employees. The company went IPO on 2007-04-19. The firm focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The firm's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The firm operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

ALMRY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	1,652	1,108	985	894	863	827
Revenue Growth (YoY)	13%	12%	10%	4%	4%	2%
Cost of Revenue	425	236	218	212	181	172
Gross Profit	1,227	871	767	682	681	654
Selling, General & Admin	515	339	291	250	253	222
Research & Development	162	96	79	66	64	41
Operating Expenses	1,098	798	718	641	626	551
Other Non Operating Income (Expenses)	-9	-8	-7	-7	-5	-7
Pretax Income	131	74	26	-17	31	-9
Income Tax Expense	50	28	16	21	26	31
Net Income	80	46	10	-38	4	-40
Net Income Growth	789%	360%	-126%	-1,050%	-110%	-154%
Shares Outstanding (Diluted)	214.58	213.99	212.74	200.64	187.94	184.4
Shares Change (YoY)	-1%	1%	6%	7%	2%	1%
EPS (Diluted)	0.37	0.21	0.04	-0.19	0.02	-0.22
EPS Growth	686%	352%	-125%	-941%	-110%	-155%
Free Cash Flow	37	37	0	-65	38	162
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	74.27%	78.61%	77.86%	76.28%	78.91%	79.08%
Operating Margin	7.8%	6.58%	4.97%	4.47%	6.25%	12.33%
Profit Margin	4.84%	4.15%	1.01%	-4.25%	0.46%	-4.83%
Free Cash Flow Margin	2.23%	3.33%	0%	-7.27%	4.4%	19.58%
EBITDA	342	224	188	164	174	221
EBITDA Margin	20.7%	20.21%	19.08%	18.34%	20.16%	26.72%
D&A For EBITDA	213	151	139	124	120	119
EBIT	129	73	49	40	54	102
EBIT Margin	7.8%	6.58%	4.97%	4.47%	6.25%	12.33%
Effective Tax Rate	38.16%	37.83%	61.53%	-123.52%	83.87%	-344.44%

Follow-Up Questions

What are Almirall SA's key financial statements?



According to the latest financial statement (Form-10K), Almirall SA has a total asset of $2,337, Net profit of $46

What are the key financial ratios for ALMRY?



Almirall SA's Current ratio is 2.74, has a Net margin is 4.15, sales per share of $5.17.

How is Almirall SA's revenue broken down by segment or geography?



Almirall SA largest revenue segment is Commercial - Own Network (Europe), at a revenue of 808,381,000 in the most earnings release.For geography, Spain is the primary market for Almirall SA, at a revenue of 305,232,000.

Is Almirall SA profitable?



yes, according to the latest financial statements, Almirall SA has a net profit of $46

Does Almirall SA have any liabilities?



yes, Almirall SA has liability of 850

How many outstanding shares for Almirall SA?



Almirall SA has a total outstanding shares of 214.78

Almirall SA (ALMRY) Financial

ALMRY Stock Price Chart